Summit Therapeutics EBITDA 2015-2024 | SMMT
- Summit Therapeutics 2023 EBITDA was -0.608B, a 773.3% increase from 2022.
- Summit Therapeutics 2022 EBITDA was -0.07B, a 16.91% decline from 2021.
- Summit Therapeutics 2021 EBITDA was -0.084B, a 63.57% increase from 2020.
EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.